Posts

Showing posts with the label vonoprazan

H Pylori: rifabutin-based therapy

  There is certainly concern about clarithromycin resistance in the treatment of H pylori. I meant to bring up an article 2 years ago of a study on rifabutin-based therapy, but it unfortunately fell off the list. rifabutin-based treatment seems to be a reasonable alternative for many people (see  hylori rifabutin rx AIM2020   in dropbox, or doi:10.7326/M19-3734)   Details: -- 455 treatment-naïve adults with epigastric discomfort and confirmed H. pylori infection, in 55 clinical research sites in the US, in the RHB-105 study (renamed ERADICATE Hp2)      -- all had dyspepsia for at least two weeks, H. pylori confirmed by  13 C urea breath test plus upper endoscopy with a positive culture, histology, or rapid urease test, prior to randomization -- mean age 47 with 93% <65 years old, 62% female, 77% white/19% Black, 60% Latinx. -- cytochrome P450 2C19 status: 20% rapid metabolizers, 50% normal metabolizers, 21% intermediate, 2% poor metabolize...